Science and Technology

Animal Biotechnology Market Sees Promising Growth Amid Technological Innovations and Increased Disease Prevention Efforts

DUBLIN, March 21, 2024 /PRNewswire/ -- A comprehensive report titled "Animal Biotechnology Market - Forecasts from 2024 to 2029" has recently been incorporated into ResearchAndMarkets.com's expansive library of market research. This forward-looking analysis offers a deep dive into the burgeoning field of animal biotechnology, highlighting key drivers, emerging trends, and the future landscape of the market.

The report lays out a projected growth trajectory for the animal biotechnology market, anticipating a compound annual growth rate (CAGR) of 6.28% during the forecast period. This surge is closely related to groundbreaking work in animal biotechnology, which has given rise to animals boasting accelerated growth rates, improved resistance to diseases, and the capability to produce therapeutic proteins essential in modern medicine.

Recent breakthroughs in the sequencing of animal genomes, gene expression studies, and a more profound understanding of animal cell metabolic profiles have revolutionized the field. Cutting-edge genome editing tools such as TALENS, CRISPR-Cas, and Zinc Finger Nucleases have paved the way for precision alterations in an animal's genetic makeup—aimed at boosting health, agricultural productivity, and disease resistance.

The Drive Towards Genetically Engineered Proteins and Preventative Care

A significant force propelling the market is the escalating demand for genetically engineered therapeutic proteins, which not only enhance disease resistance but also are increasingly employed in cancer treatments and broader preventative care measures for animals. This heightened demand correlates with the expanding utilization of animals in agricultural settings, meat production, and the creation of animal-based products.

Public concern for animal health and welfare has grown, augmenting the role of animals in producing human pharmaceuticals. The trend of animal adoption has also contributed to market growth, stimulating further interest and investment in animal biotechnology initiatives.

Battling Obesity, Inflammation, and Cancer in Dogs

One of the most pressing nutritional dilemmas in the canine world is obesity, which has seen a disturbing uptick in many countries. This has become a central driving factor propelling the animal biotechnology market expansion. Obesity triggers chronic low-grade inflammation, which is widely accepted as a precursor to numerous health issues. Conclusive evidence suggests a correlation between obesity and an elevated risk of developing certain types of cancers in dogs. As obesity rates increase, so too does the prevalence of cancer among canines, leading to it becoming a significant cause of mortality for these beloved pets.

Stepping up Government Initiatives for Animal Health

India has been making strides in animal pandemic preparedness, aligning with the One Health approach. Shri Parshottam Rupala, Union Minister for Fisheries, Animal Husbandry, and Dairy, unveiled the Animal Pandemic Preparedness Initiative along with a World Bank-funded Animal Health System Support for One Health project. This concerted initiative focuses on enhancing India's readiness to deal with animal pandemics by addressing zoonotic diseases that pose threats to both animal and human health. The initiative fosters farmer awareness, strengthens veterinary services, betters disease surveillance, and empowers animal health experts through community engagement efforts.

The Surge in Vaccine Demand

A crucial factor driving the growth of the animal biotechnology market is the rising prevalence of animal diseases. These diseases can transfer from animals to humans through direct contact, consumption of contaminated food or water, or other environmental factors. A testament to the dedication of this sector is the NANDI (NOC Approval for New Drug and Inoculation System) status, which was revealed in June 2023 and illustrates progress made towards the Animal Pandemic Preparedness Initiative's goals. Furthermore, July 2023 marked the inauguration of the Centre on Vaccine Evaluation and Alternatives for Antimicrobials at Kansas State University's College of Veterinary Medicine, propelling forward the development and utilization of animal vaccines.

North America: A Robust Market for Animal Biotechnology

It is anticipated that North America will maintain a steady growth pace within the animal biotechnology market, bolstered by comprehensive healthcare programs and rising endeavors to ameliorate animal health. One can attribute this potential to significant research and development investments in the region, which are expected to fast-track the market's expansion. For instance, a notable initiative by the National Institute of Standards and Technology (NIST) and the U.S. Food and Drug Administration declared in May 2023 focuses on genome editing technologies to enhance animal genomes, demonstrating the FDA's continued commitment to promoting responsible biotechnology product development.

Spotlight on the Center for Veterinary Medicine (CVM)

The Center for Veterinary Medicine (CVM) upholds its commitment to fostering breakthrough technologies for crafting secure and effective products while maintaining public trust through a science-based and risk-centered regulatory foundation. CVM is at the vanguard of advancing innovative animal products in the realms of Intentional Genomic Alterations (IGAs) in animals and Animal Cell Transplantation Products (ACTPs).

To support the pioneering development of such products, CVM introduced the Veterinary Innovation Programme (VIP). This initiative seeks to demystify the regulatory processes, bolster research and development efforts, and offer a clear and predictable pathway to approvals for ACTPs and IGAs in animals.

Major Government Programs in Focus

A couple of government initiatives have had a transformative effect on the animal biotechnology landscape:

• The One Health Centre at the National Institute of Animal Biotechnology (NIAB) in Hyderabad was established to enrich collaboration across a broad spectrum of sectors, including veterinary, medical, agricultural, and environmental disciplines. This coordination aims to recognize and mitigate zoonoses and transboundary animal diseases.
• The Department of Biotechnology (DBT) and TANUVAS-Chennai partnered to launch the Translational Research Platform for Veterinary Biologicals (TRPVB). This alliance focuses on translating new discoveries in the sphere of veterinary biologicals, vaccines, and diagnostics into practical applications, ensuring the economic elevation of farmland and the amelioration of animal health and productivity.

Company Profiles: Leaders Shaping the Future

Several key players featured within the report include:

• Zeus Biotech Pvt. Ltd.
• Invetx
• Ingenta Connect
• Kingfisher Biotech
• Animab
• Boehringer Ingelheim
• Beveridge & Diamond PC
• RSPCA
• Santa Cruz Biotechnology
• Pfizer

These companies are at the forefront of animal biotechnology research and have contributed invaluable innovations to the field.

Report Segmentation: A Closer Look at Market Dynamics

The report segments the animal biotechnology market to provide a granulated viewpoint on its various components. These segments include:

By Product

• Diagnostic Tests
• Vaccines
• Drugs
• Reproductive and Genetic Medications
• Feed Additives

By Application

• Diagnosis of Animal Disease
• Treatment of Animal Disease
• Preventive Care of Animals
• Drug Development
• Other Applications

By End Use

• Laboratories
• In-house Testing
• Clinics
• Others

By Geography

The geographical segmentation of the market paints a picture of its distribution and growth patterns worldwide, detailed as follows:

North America

• United States
• Canada
• Mexico

South America

• Brazil
• Argentina
• Others

Europe

• United Kingdom
• Germany
• France
• Spain
• Others

Middle East and Africa

• Saudi Arabia
• UAE
• Israel
• Others

Asia Pacific

• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others

Additional Information and Market Insights

For more insights into this burgeoning market, access the full report at ResearchAndMarkets.com.

About ResearchAndMarkets.com

ResearchAndMarkets.com holds the esteemed position as the world's preeminent source for international market research and market data. The organization takes pride in providing up-to-the-minute data on global and regional markets, leading industries, top-tier companies, cutting-edge products, and recent market trends.

Media Contact:

For further details and media inquiries, please contact:

Laura Wood, Senior Manager Email: [email protected]
For EST Office Hours Call: +1-917-300-0470
For U.S./CAN Toll Free Call: +1-800-526-8630
For GMT Office Hours Call: +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Explore ResearchAndMarkets.com's logo at this link.

SOURCE: Research and Markets